261Y000250 - Medicines from CPA 2025/1589

This tender, identified by reference 261Y000250, concerns the acquisition of medicines related to CPA 2025/1589. CPA likely refers to a specific contract, program, or framework agreement, and the numbers indicate a particular period or reference within that framework. The core objective is to procure pharmaceutical products as defined by this specific CPA. The tender will detail the exact list of medicines, their required specifications (dosage, form, manufacturer if applicable), quantities, and delivery schedules. Bidders are expected to be authorized pharmaceutical suppliers capable of meeting stringent quality and regulatory requirements. Evaluation will focus on compliance with the specified medicines, adherence to quality standards, pricing, and supply chain reliability. This procurement ensures the availability of necessary medications under the established framework agreement (CPA 2025/1589).

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,807.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.